Lorem ipsum dolor sit amet, consectetur elit, sed do eiusmod tempor incididunt ut labore et magna aliqua. Ut enim ad minim veniam laboris.

Mon - Fri 8:00 - 6:30

Health & Wellness

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

unlock this story instantly and join members and pros reading HALO daily -It's Free